Feasibility and potential diagnostic value of [18F]PI-2620 PET in patients with down syndrome and Al...
Feasibility and potential diagnostic value of [18F]PI-2620 PET in patients with down syndrome and Alzheimer’s disease: a case series
About this item
Full title
Author / Creator
Publisher
Switzerland: Frontiers Media S.A
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: Frontiers Media S.A
Subjects
More information
Scope and Contents
Contents
Adults with Down Syndrome (DS) have a substantially increased risk for Alzheimer's disease (AD) due to the triplicated amyloid-precursor-protein gene on chromosome 21, resulting in amyloid and tau accumulation. However, tau PET assessments are not sufficiently implemented in DS-AD research or clinical work-up, and second-generation tau tracers such...
Alternative Titles
Full title
Feasibility and potential diagnostic value of [18F]PI-2620 PET in patients with down syndrome and Alzheimer’s disease: a case series
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ba2cfbe66a584ca7becb7f7afba05f4e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ba2cfbe66a584ca7becb7f7afba05f4e
Other Identifiers
ISSN
1662-453X,1662-4548
E-ISSN
1662-453X
DOI
10.3389/fnins.2024.1505999
